Media Summary: Presented by Shannon McArdel DayCON 2015: Bio-Medley June 6, 2015 **See for complete ... Using neurons made from the stem cells of children with ... Dr Amit Aggarwal Executive Director Medical Affairs, Association of the British

Bench To Bedside Drug Discovery - Detailed Analysis & Overview

Presented by Shannon McArdel DayCON 2015: Bio-Medley June 6, 2015 **See for complete ... Using neurons made from the stem cells of children with ... Dr Amit Aggarwal Executive Director Medical Affairs, Association of the British BIA's Science and Innovation Advisory Committee (SIAC) are delivering a series of webinars in 2019 entitled ' Alexander Fleming predicted the rise of antibiotic resistance before it had even started. In recent years researchers have been ... The goal of this webinar was to provide a high-level overview of the various stages of preclinical cancer

Four FDA scientists explain the Good Manufacturing Practices to firms that are ready to bring This video discusses FDA programs that are designed to support rare disease product A Kinexum webinar on catalyzing the transition from

Photo Gallery

From Bench to Bedside: The Drug Discovery Pipeline
Bench to Bedside: Drug Discovery in Neuroscience - Ricardo Dolmetsch
Drug discovery - the journey from bench to bedside
Bench to bedside: episode 1 - "walking the critical path"
Bench to Bedside: Episode 2 - "Harnessing 'Omics"
Bench To Bedside S9E10:  Cancer drugs: The journey from the lab to the patient's bedside
Antibiotics - from bench to bedside
The Bench to Bedside Series: Preclinical Cancer Research with Scintica
Bench to Bedside: Episode 4 - "From Biomarker to Surrogate"
Bench to Bedside Chats: Guidance for Industry CGMP for Phase 1 Investigational Drugs
From Bench to Bedside and Back Again 3.24.2026
Bench to Bedside Chat- “Drug Development for Economically Infeasible Indications”
View Detailed Profile
From Bench to Bedside: The Drug Discovery Pipeline

From Bench to Bedside: The Drug Discovery Pipeline

Presented by Shannon McArdel DayCON 2015: Bio-Medley June 6, 2015 **See http://sitn.hms.harvard.edu/daycon/ for complete ...

Bench to Bedside: Drug Discovery in Neuroscience - Ricardo Dolmetsch

Bench to Bedside: Drug Discovery in Neuroscience - Ricardo Dolmetsch

https://www.ibiology.org/human-disease/neurodevelopmental-disease/ Using neurons made from the stem cells of children with ...

Drug discovery - the journey from bench to bedside

Drug discovery - the journey from bench to bedside

Dr Amit Aggarwal Executive Director Medical Affairs, Association of the British

Bench to bedside: episode 1 - "walking the critical path"

Bench to bedside: episode 1 - "walking the critical path"

BIA's Science and Innovation Advisory Committee (SIAC) are delivering a series of webinars in 2019 entitled '

Bench to Bedside: Episode 2 - "Harnessing 'Omics"

Bench to Bedside: Episode 2 - "Harnessing 'Omics"

BIA's Science and Innovation Advisory Committee (SIAC) are delivering a series of webinars in 2019 entitled '

Bench To Bedside S9E10:  Cancer drugs: The journey from the lab to the patient's bedside

Bench To Bedside S9E10: Cancer drugs: The journey from the lab to the patient's bedside

Have you ever wondered how

Antibiotics - from bench to bedside

Antibiotics - from bench to bedside

Alexander Fleming predicted the rise of antibiotic resistance before it had even started. In recent years researchers have been ...

The Bench to Bedside Series: Preclinical Cancer Research with Scintica

The Bench to Bedside Series: Preclinical Cancer Research with Scintica

The goal of this webinar was to provide a high-level overview of the various stages of preclinical cancer

Bench to Bedside: Episode 4 - "From Biomarker to Surrogate"

Bench to Bedside: Episode 4 - "From Biomarker to Surrogate"

BIA's Science and Innovation Advisory Committee (SIAC) are delivering a series of webinars in 2019 entitled '

Bench to Bedside Chats: Guidance for Industry CGMP for Phase 1 Investigational Drugs

Bench to Bedside Chats: Guidance for Industry CGMP for Phase 1 Investigational Drugs

Four FDA scientists explain the Good Manufacturing Practices to firms that are ready to bring

From Bench to Bedside and Back Again 3.24.2026

From Bench to Bedside and Back Again 3.24.2026

MAA Webinar | From

Bench to Bedside Chat- “Drug Development for Economically Infeasible Indications”

Bench to Bedside Chat- “Drug Development for Economically Infeasible Indications”

This video discusses FDA programs that are designed to support rare disease product

From Bench to Bedside

From Bench to Bedside

A Kinexum webinar on catalyzing the transition from